PDS Biotechnology
PDSB
PDSB
43 hedge funds and large institutions have $11M invested in PDS Biotechnology in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
59% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 29
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$847K | |
2 | +$773K | |
3 | +$507K | |
4 |
Two Sigma Investments
New York
|
+$242K |
5 |
ARTA
A.R.T. Advisors
New York
|
+$241K |
Top Sellers
1 | -$865K | |
2 | -$420K | |
3 | -$360K | |
4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$337K |
5 |
Northern Trust
Chicago,
Illinois
|
-$176K |